Why are Clorox shares up 3.8% today?

Traders Union
All News
Stocks
Clorox surges 3.87% today to $102.06

Highlights

Clorox raised its quarterly dividend to $1.25 per share, marking 49 consecutive years of increases and reinforcing its commitment to capital returns.
Fiscal 2027 guidance points to adjusted EPS of $5.70 to $6.00 and revenue of $7.6 to $7.7 billion, with inflationary pressures expected to raise input costs by over $200 million.
Clorox stock trades near $102.06, with short-term momentum signaling overbought conditions and a forecasted range of $99.11 to $107.28 for the next five trading days.

Upbeat outlooks counter cost headwinds amid dividend pledge

Clorox reported financial results for the fourth quarter and fiscal year ending June 30, 2026, and raised its quarterly dividend to $1.25 per share, marking the 49th straight year of increases. The company issued guidance for fiscal 2027, expecting adjusted earnings per share between $5.70 and $6.00 and revenue of $7.6 to $7.7 billion. Clorox also projects that inflation in commodities and logistics will exceed $200 million, with its newly integrated Purell/GOJO business contributing positively to earnings. Management reaffirmed its commitment to the dividend and maintaining strong cash flow targets, amid ongoing challenges from input cost volatility, supply risks, and heightened competition.

Anton Kharitonov, expert at Traders Union, observes that Clorox’s 49-year dividend streak and raised guidance have lifted sentiment but have not resolved long-term concerns. He highlights the ongoing struggle below the 200-day moving average as a sign that structural weakness remains. Kharitonov notes persistent risks from inflation, supply disruptions, and fierce competition, which could weigh on future earnings and cash flow. He points out overshooting in momentum indicators, warning of possible overextension. "Investors should remain defensive, as recent gains could fade quickly if support at $99.11 breaks," he states.

Viktoras Karapetjanc, expert at Traders Union, sees strong prospects for Clorox following the company’s increased dividend and optimistic outlook for fiscal 2027. He believes robust cash flow targets and the integration of Purell/GOJO reinforce the bullish structure. Karapetjanc views management’s confidence and clear guidance as key drivers for further buying. He expects the market to reward the company’s resilience to input cost pressures. "This setup signals further growth as Clorox positions for a breakout toward $107.28 in the near term," he asserts.

Parshwa Turakhiya, analyst, sees momentum aligning with positive news flow, sparking short-term opportunities for traders. He notes that most indicators are bullish, with resistance at $102.53 and potential for upward movement if this level is surpassed. Turakhiya cautions that overbought signals and high volatility call for patience, as quick reversals remain possible. "I’d watch for a sideways move as the market tests conviction above $102.53 before chasing further gains," he advises.

Short-term bullish momentum tempered by overbought signals

Clorox is trading above both its 20-day and 50-day moving averages ($96.38 and $95.52), indicating short- and medium-term strength, but still remains below the 200-day moving average at $104.14, which suggests lingering long-term bearishness. Key resistance for the session stands at $102.53, with near-term support at $100.45. Most momentum indicators reflect a bullish setup: MACD and RSI both signal a buy, and the Awesome Oscillator underlines prevailing intraday strength. However, the CCI and Stochastic RSI point to mildly overbought conditions, and both the ADX and BBP signal elevated but potentially cautious momentum, as intraday buyers dominate.

Earlier, analysts noted that Clorox was showing short- and medium-term technical strength but continued to face mixed longer-term signals below key moving averages. The latest quarterly results and forward guidance reinforce this short-term momentum, with traders now advised to monitor $102.53 as a breakout level that could shift the stock into a higher trading range.

Source of Data: CLX Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.